Clinical Trial

Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2025 (before its estimated March 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of Lifitegrast Ophthalmic Solution.
Trial Details
NCT Number NCT06879782
Lead Sponsor Lunan Better Pharmaceutical Co., LTD.
Collaborators: Beijing Tongren Hospital
Conditions Dry Eye Disease (DED)
Enrollment 820 participants
Start Date 2024-03-28
Primary Completion 2026-03-28 (estimated)
Study Completion 2026-09-28 (estimated)
Updated on ClinicalTrials.gov 2025-03-17